FI71555C - Foerfarande foer framstaellning av farmakologiskt vaerdefull 4-(2-pyridylamino)isoftalsyra. - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefull 4-(2-pyridylamino)isoftalsyra. Download PDF

Info

Publication number
FI71555C
FI71555C FI782039A FI782039A FI71555C FI 71555 C FI71555 C FI 71555C FI 782039 A FI782039 A FI 782039A FI 782039 A FI782039 A FI 782039A FI 71555 C FI71555 C FI 71555C
Authority
FI
Finland
Prior art keywords
cooh
formula
preparation
isophthalic acid
compound
Prior art date
Application number
FI782039A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI782039A (fi
FI71555B (fi
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Armin Fuegner
Volker Jacobi
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI782039A publication Critical patent/FI782039A/fi
Application granted granted Critical
Publication of FI71555B publication Critical patent/FI71555B/fi
Publication of FI71555C publication Critical patent/FI71555C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
FI782039A 1977-08-10 1978-06-27 Foerfarande foer framstaellning av farmakologiskt vaerdefull 4-(2-pyridylamino)isoftalsyra. FI71555C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2735919 1977-08-10
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (3)

Publication Number Publication Date
FI782039A FI782039A (fi) 1979-02-11
FI71555B FI71555B (fi) 1986-10-10
FI71555C true FI71555C (fi) 1987-01-19

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782039A FI71555C (fi) 1977-08-10 1978-06-27 Foerfarande foer framstaellning av farmakologiskt vaerdefull 4-(2-pyridylamino)isoftalsyra.

Country Status (32)

Country Link
US (1) US4241068A (el)
JP (1) JPS5430177A (el)
AT (1) AT370415B (el)
AU (1) AU520240B2 (el)
BE (1) BE869640A (el)
BG (1) BG30472A1 (el)
CA (1) CA1111037A (el)
CH (1) CH649289A5 (el)
CS (1) CS202506B2 (el)
DD (1) DD140351A5 (el)
DE (1) DE2735919A1 (el)
DK (1) DK148019C (el)
ES (5) ES472143A1 (el)
FI (1) FI71555C (el)
FR (1) FR2400017A1 (el)
GB (1) GB2002764B (el)
GR (1) GR65024B (el)
HU (1) HU179933B (el)
IE (1) IE47228B1 (el)
IT (1) IT1107960B (el)
LU (1) LU80094A1 (el)
MX (1) MX5672E (el)
NL (1) NL7808319A (el)
NO (1) NO152605C (el)
NZ (1) NZ188101A (el)
PH (1) PH19117A (el)
PL (2) PL115778B1 (el)
PT (1) PT68407A (el)
SE (1) SE444170B (el)
SU (2) SU735168A3 (el)
YU (1) YU40832B (el)
ZA (1) ZA784501B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (el) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
NO782707L (no) 1979-02-13
CH649289A5 (de) 1985-05-15
CA1111037A (en) 1981-10-20
PL115778B1 (en) 1981-04-30
ZA784501B (en) 1980-04-30
DK148019C (da) 1985-07-01
BE869640A (fr) 1979-02-09
DD140351A5 (de) 1980-02-27
ATA549278A (de) 1982-08-15
ES472143A1 (es) 1979-03-16
IE781618L (en) 1979-02-10
YU191678A (en) 1983-01-21
HU179933B (en) 1983-01-28
DK148019B (da) 1985-02-04
AT370415B (de) 1983-03-25
PL115889B1 (en) 1981-05-30
JPS5430177A (en) 1979-03-06
JPS6231704B2 (el) 1987-07-09
SE7808530L (sv) 1979-02-11
NO152605B (no) 1985-07-15
BG30472A1 (en) 1981-06-15
AU3877278A (en) 1980-02-14
FI782039A (fi) 1979-02-11
DE2735919A1 (de) 1979-02-22
GR65024B (en) 1980-06-16
LU80094A1 (de) 1979-09-07
PH19117A (en) 1986-01-06
FI71555B (fi) 1986-10-10
SU886743A3 (ru) 1981-11-30
GB2002764A (en) 1979-02-28
ES475456A1 (es) 1979-05-01
NL7808319A (nl) 1979-02-13
AU520240B2 (en) 1982-01-21
NZ188101A (en) 1981-01-23
FR2400017B1 (el) 1983-03-11
IT7850642A0 (it) 1978-08-08
GB2002764B (en) 1982-08-04
DE2735919C2 (el) 1988-10-27
CS202506B2 (en) 1981-01-30
NO152605C (no) 1985-10-23
SE444170B (sv) 1986-03-24
PL208942A1 (el) 1979-12-03
MX5672E (es) 1983-12-08
SU735168A3 (ru) 1980-05-15
US4241068A (en) 1980-12-23
ES475457A1 (es) 1979-11-16
DK351978A (da) 1979-02-11
ES480622A1 (es) 1980-01-01
PT68407A (de) 1978-09-01
IE47228B1 (en) 1984-01-25
FR2400017A1 (fr) 1979-03-09
IT1107960B (it) 1985-12-02
YU40832B (en) 1986-06-30
ES480623A1 (es) 1980-01-01

Similar Documents

Publication Publication Date Title
US4038396A (en) Anti-inflammatory oxazole[4,5-b]pyridines
CA1109470A (en) Xanthine derivatives
DE3142982A1 (de) Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
FI64359B (fi) Analogifoerfarande foer framstaellning av terapeutiskt verksamma 3,4-dihydro-4-oxo-kinazolinderivat
FI71555C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull 4-(2-pyridylamino)isoftalsyra.
US3478040A (en) Glyceryl 2-(x,y,z-substituted anilino) nicotinates
EP0290915B1 (de) Flavon-3-carbonsäure-Verbindungen sowie Verfahren, Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA1200243A (en) 5-oxo-5h-¬1|benzopyrano¬2,3-b|pyridine derivatives, their production and use
US3748325A (en) Process for the preparation of quinazolinone derivatives
SE431985B (sv) Analogiforfarande for framstellning av imidazo/1,2-a/kinoliner
EP0005154B1 (de) 1-Oxo-1H-pyrimido (6,1-b) benzthiazol-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0012925B1 (de) Neue Chinoloncarbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CH616934A5 (en) Process for the preparation of chromone derivatives
DE69106499T2 (de) Chromenderivate, deren herstellung und verwendung.
US4131677A (en) Anti-inflammatory oxazolo [5,4-b]pyridines
DE3875820T2 (de) Aromatische heterozyklische karbonsaeureamidabkoemmlinge, verfahren zur herstellung und arzneimittel, die diese enthalten.
EP0862550B1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
US3470165A (en) Furochromone derivatives
DE3505576A1 (de) Vorwirkstoffe entzuendungshemmender oxicame und solche vorwirkstoffe enthaltende pharmazeutische zusammensetzungen
WO2001014344A2 (de) Mehrcyclische pyrimidin-2,4(1h, 3h)-dione mit funktionalisierten alkylresten in 1- und/oder 3-position, verfahren zu ihrer herstellung und pharmazeutische zubereitungen
McLean et al. 544. The application of the Hofmann reaction to the synthesis of heterocyclic compounds. Part VII. Synthesis of pyridinopyrimidine derivatives
DE2701511A1 (de) Thieno(3,2-c)pyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH660011A5 (de) Substituierte carboxy-thiazolo-(3,2-a)-pyrimidin-derivate.
JPS61137881A (ja) クロメン誘導体、その製法およびそれを有効成分とする抗アレルギ−剤
DE2907153A1 (de) 7 beta -(5-oxo-4-phenylimidazolidin- 1-yl)-3-chlor-3-cephem-4-carbonsaeurederivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN